Cardinal Health, Inc. $CAH Shares Sold by Kingswood Wealth Advisors LLC

Kingswood Wealth Advisors LLC lessened its position in Cardinal Health, Inc. (NYSE:CAH) by 24.7% during the second quarter, Holdings Channel reports. The fund owned 2,348 shares of the company’s stock after selling 771 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in Cardinal Health were worth $395,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Cardinal Health by 3.6% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock worth $297,000 after acquiring an additional 62 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its stake in Cardinal Health by 0.4% during the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock valued at $2,991,000 after buying an additional 69 shares during the period. Perigon Wealth Management LLC increased its stake in Cardinal Health by 3.2% during the 2nd quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock valued at $389,000 after buying an additional 72 shares during the period. Community Bank & Trust Waco Texas increased its stake in Cardinal Health by 1.3% during the 2nd quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock valued at $940,000 after buying an additional 74 shares during the period. Finally, Pinnacle Bancorp Inc. increased its stake in Cardinal Health by 11.2% during the 1st quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company’s stock valued at $106,000 after buying an additional 77 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of CAH opened at $156.86 on Friday. The firm’s 50 day moving average is $152.09 and its 200-day moving average is $151.09. The stock has a market capitalization of $37.27 billion, a P/E ratio of 24.32, a P/E/G ratio of 1.33 and a beta of 0.71. Cardinal Health, Inc. has a 12-month low of $106.98 and a 12-month high of $168.44.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.03 by $0.05. The company had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business’s revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.63%.

Analyst Ratings Changes

Several research firms have commented on CAH. Leerink Partners raised their target price on shares of Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a research note on Monday, October 6th. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Argus set a $189.00 target price on shares of Cardinal Health in a research note on Friday, August 22nd. UBS Group reissued a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $166.00.

Insider Buying and Selling

In other Cardinal Health news, CEO Jason M. Hollar sold 107,705 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total value of $16,037,274.50. Following the completion of the transaction, the chief executive officer directly owned 235,901 shares in the company, valued at $35,125,658.90. This trade represents a 31.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Michelle D. Greene sold 13,500 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the transaction, the insider owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. The trade was a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 271,676 shares of company stock valued at $40,489,525. Company insiders own 0.12% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.